Catalog Number 810041B |
Device Problem
Material Erosion (1214)
|
Patient Problems
Erosion (1750); Unspecified Infection (1930); Internal Organ Perforation (1987); Pain (1994); Other (for use when an appropriate patient code cannot be identified) (2200); Surgical procedure (2357)
|
Event Type
Injury
|
Event Description
|
It was reported by an attorney that the patient underwent that a patient underwent sling procedure on (b)(6) 2011.It was reported that she experienced pain, erosion of her internal bodily tissue and other injuries following the procedure.It was reported that the patient has undergone multiple surgeries and revisionary procedures.No additional information was provided.
|
|
Manufacturer Narrative
|
(b)(4).Conclusion: no conclusion can be drawn at this time.Should additional information be obtained, a supplemental 3500a form will be submitted accordingly.In addition, a review of the batch manufacturing records was conducted and the batch met all finished goods release criteria.(b)(4).Total number of events - (b)(4).Gynecare tvt - 203.Gynecare tvt abrevo continence system - (b)(4).Gynecare tvt exact continence system - (b)(4).Gynecare tvt obturator system - (b)(4).Gynecare tvt retropubic system - (b)(4).Gynecare tvt-aa abdominal - (b)(4).
|
|
Manufacturer Narrative
|
The indication for procedure was stress urinary incontinence.It was reported that following insertion the patient experienced pain, infection, urinary problems, organ perforation, and recurrence.(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).Ethicon mdr summary reporting exemption (b)(4).Reporting period (b)(6) 2014.
|
|
Manufacturer Narrative
|
(b)(4).Reporting period (b)(4) 2014.
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).Reporting period october 1 2014 through november 30, 2014.
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).Reporting period october 1 2014 through november 30, 2014.
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
Date sent to the fda: 12/20/2017.Ethicon mdr summary reporting exemption (b)(4).Reporting period (b)(4) 2014 through (b)(4) 2014.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1 2014 through november 30, 2014.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1 2014 through november 30, 2014.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1 2014 through november 30, 2014.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1 2014 through november 30, 2014.
|
|
Manufacturer Narrative
|
Date sent to fda: 12/26/2018.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1 2014 through november 30, 2014.
|
|
Manufacturer Narrative
|
Date sent to fda: 2/12/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2014 through november 30, 2014.
|
|
Manufacturer Narrative
|
Date sent to fda: 04/24/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2014 through november 30, 2014.
|
|
Manufacturer Narrative
|
Date sent to the fda: 10/28/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1 2014 through november 30, 2014.
|
|
Manufacturer Narrative
|
Date sent to fda: 06/23/2020.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2014 through november 30, 2014.
|
|
Search Alerts/Recalls
|